Samsung Electronics, a leader in medical imaging technology, is showcasing its latest Ultrasound, Digital Radiography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI) concept and their software innovations at the Radiological Society of North America (RSNA) 2018 Annual Meeting at McCormick Place in Chicago.

“We are pleased that Samsung’s AI technologies have been successfully applied to the existing diagnostic imaging devices and have been well received in the market,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “As a comprehensive diagnostic imaging solution provider, we will continue to strengthen our technologies through collaboration with hospitals and healthcare professionals. We aim to bring together radiologists and AI to fill in the gaps for improved healthcare management.”

Samsung showcases several types of AI based diagnostic imaging software:

• Ultrasound System – S-Detect for Breast is AI based software which analyzes breast lesions using ultrasound images, and has been implemented into Samsung’s ultrasound systems dedicated to Radiology. It assists in standardizing reports and classification of suspicious breast lesions by incorporating BIRADS® ATLAS* (Breast Imaging-Reporting and Data System, Atlas)

According to a recently published study¹ by radiology professor Tommaso Bartolotta from the University of Palermo in Italy, S-Detect for Breast has shown to assist various degrees of improvement in the overall diagnosis of breast lesions. When using S-Detect for Breast, the diagnostic accuracy for doctors with experience of four years or less improved from 0.83 to 0.87 (AUC, Area Under Curve). S-Detect for Breast could be a useful tool for supporting and guiding breast diagnosis among non-expert breast imaging physicians (Only shape and orientation descriptors are automatically classified in the United States).

• Digital Radiography – By using AI technology, the ‘Bone Suppression’ function, which reduces the bone signal from the chest x-ray image, clearly brings out the lung tissues obscured by the bones. ‘SimGrid’ has also been introduced as a solution to ease the workflow to replace grids, while providing excellent image quality with reduced scatter artifacts. According to a recently published study², ‘SimGrid’ provided image quality almost as good as the images taken with a physical grid.

The Auto Lung Nodule Detection (ALND) is a CAD (Computer Aided Detection) solution based on AI technology used in the detection of lung nodules and is 510(k) pending. According to a recent  study³in press in Journal of Thoracic Imaging, ALND improved the detection sensitivity of lung cancer nodules 3 cm or smaller in chest radiographs by seven percentage points to 92 percent, compared with the average of six chest radiologists.

• Computed Tomography – Samsung has introduced the intra-cranial hemorrhage package that combines a mobile stroke unit with a radiological computer aided triage and notification solution based on AI technology.

• Magnetic Resonance Imaging – Utilizing AI technology, Samsung is developing a technology to display information such as knee cartilage thickness as well as images of knee arthritis patients. The software is a prototype and not for sale in any region of the world.

At the Samsung booth, attendees will find a separate ‘AI zone’ that allows visitors to experience Samsung’s AI technology more easily. Samsung will also host a symposium that will demonstrate how its image processing technology improves diagnostic accuracy and promote radiation safety for pediatric patients.

Through the release of new diagnostic tools that utilize diverse data based on AI technology, Samsung will continue to support healthcare professionals to improve the diagnostic accuracy.

For more information on Samsung’s healthcare business, and products, please visit https://www.samsunghealthcare.com.

About Samsung Medison

Samsung Medison is a global leading medical device company, founded in 1985. With a mission to bring health and well-being of people’s lives, the company manufactures diagnostic ultrasound systems around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

¹Tommaso Vincenzo Bartolotta, et al. Focal breast lesion characterization according to the BIRADS US lexicon: role of a computer aided decision making support. La radiologia medica. 2018 Mar 22

²S. Y. Ahn, et al. The Potential Role of Grid-Like Software in Bedside Chest Radiography in Improving Image Quality and Dose Reduction: An Observer Preference Study. Korean J Radiol, 2018; 19(3):526-533

³M.J. Cha, et al. Performance of Deep Learning Model in Detecting Operable Lung Cancer with Chest Radiographs. J Thorac Imaging, 2018 In press

The release of OmniTom^® is the latest demonstration of Samsung’s leadership in CT imaging. OmniTom^® features an array of improvements from Samsung’s award-winning CereTom CT scanner, including:

• Improved workflow: OmniTom^® is the world’s first mobile imaging device with omni-directional wheels, maximizing mobility and allowing easier and quieter movement in small spaces.
• Superior image quality: 16-slice (0.625 mm per slice) advanced data acquisition system with a 50 percent increase in CNR versus other portable CT technologies.
• Expanded use: Maintains a small footprint ideal for mobile use while increasing the gantry opening to 40 cm for improved coverage of adult head and neck, and full body pediatric scanning.
• Enhanced safety system: OmniTom^® features an internal drive system, making portability less strenuous, while also offering smart-sensing collision avoidance software to maximize control and patient safety.

OmniTom^® is ideal for cranial procedures and is designed to deliver the highest quality non-contrast CT, CT angiography and CT perfusion scans. The combination of its rapid scan time, ultra-small footprint and immediate image viewing makes OmniTom^® an indispensable tool for collecting real-time data on critically ill patients.

The latest product also demonstrates Samsung’s “AccE” (Access, Accuracy and Efficiency) strategy that aims to change the industry by incorporating innovations in physical access to provide care wherever it is needed. It also aims to improve accuracy in diagnosis with advanced algorithms and efficiency with advanced display, UX and information management technology developed by Samsung Electronics.

“OmniTom^® embodies Samsung’s commitment to providing leading technologies to healthcare providers by combining our key values of Access, Accuracy and Efficiency,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “We’ve made a CT product that’s lighter, more mobile, more accurate and faster, and we hope the many doctors and technicians here at RSNA will be able to use it to benefit their patients.”

“At Samsung, we work tirelessly to make sure that our full range of products provide patients and physicians with the best possible options for care” added Philip Sullivan, President and CEO Samsung NeuroLogica. “We do this through designing products that deliver broad access, superior accuracy and quality, and make care teams more efficient by maximizing throughput and minimizing waste.”

In addition to OmniTom^®, Samsung will be showcasing its spectral CT with Photon Counting Detector (PCD), the next generation of CT technology. Samsung’s team will also be demonstrating a range of healthcare solutions in mobile CT, Digital Radiography and Ultrasound that are all designed to bridge the care-delivery gap and maximize efficiency to enhance the patient experience. Such solutions include:

• Ultrasound Segment: Samsung will feature their comprehensive general imaging ultrasound portfolio, including the new HS60 and HS40 ultrasound systems which were introduced earlier this year. The RS80A with Prestige, Samsung’s premium general imaging ultrasound system, will be displayed in three daily educational demonstrations featuring live scanning. The RS80A includes innovative technologies for the busy radiology department that help boost clinical confidence. Based on its achievements in ultrasonic diagnosis devices for obstetrics and gynecology, the company is strengthening its premium ultrasonic diagnosis device business for radiology, which has the biggest market potential.

• Digital Radiography Segment: Samsung will display a wide range of its portfolio including two ceiling-mounted systems, GC85 and GC70, as well as highlight its premium portable GM85 X-ray. The GM85’s enhanced mobility and streamlined workflow will enable users to experience a new level of efficiency along with exceptional image quality. Samsung has also differentiated itself from its competitors by adopting low dose technology for enhanced patient safety.

• Magnetic Resonance Imaging Segment: Samsung will be showcasing a prototype of Specialty MRI, an MRI imaging device for arms and/or legs. The prototype is expected to be a game changer in the industry: It is designed to maximize not only cost and space but also patient convenience, as it eliminates the need for the whole body to be in the MRI device.

Learn more by visiting Samsung at booth #2543 (South Building, Hall A) at the RSNA 2017 Annual Meeting, as well as following Samsung NeuroLogica on Facebook, Twitter and LinkedIn.

About Samsung NeuroLogica

Samsung NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures and markets innovative imaging technologies, and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. Samsung NeuroLogica, the global corporate headquarters and manufacturer of Samsung computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. Samsung NeuroLogica’s growing portfolio of advanced medical technologies are used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. Samsung is committed to being leaders in the field of healthcare imaging. For more information, please visit www.SamsungNeuroLogica.com.